{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:08:29Z","timestamp":1775927309850,"version":"3.50.1"},"reference-count":194,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomarkers Med."],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.2217\/bmm.13.135","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T10:22:32Z","timestamp":1386757352000},"page":"29-49","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Use of Translational Pharmacodynamic Biomarkers in Early-Phase Clinical Studies for Schizophrenia"],"prefix":"10.1080","volume":"8","author":[{"given":"Brett A","family":"English","sequence":"first","affiliation":[{"name":"Parexel International,\rGlendale,\rCA,\rUSA"},{"name":"Department of Pharmacology,Vanderbilt University,\rNashville,\rTN, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelan","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice,Touro University California College of Pharmacy,\rVallejo,\rCA,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Q-Metrx Inc.,\rBurbank,\rCA,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bazih","sequence":"additional","affiliation":[{"name":"SMRT Image Inc.,\rLos Angeles,\rCA,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Gertsik","sequence":"additional","affiliation":[{"name":"California Clinical Trials Medical Group,\rGlendale,\rCA, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Ereshefsky","sequence":"additional","affiliation":[{"name":"Parexel International,\rGlendale,\rCA,\rUSA"},{"name":"The University of Texas at Austin,College of Pharmacy,\rAustin,\rTX,\rUSA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,12,11]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.2.176"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1018"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002062"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.043554"},{"key":"e_1_3_2_3_5_1","first-page":"795","article-title":"The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development.","volume":"11","author":"Soares HD","year":"2010","unstructured":"Soares HD .The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development.Curr. Opin. Investig. Drugs.11 , 795\u2013801 (2010).","journal-title":"Curr. Opin. Investig. Drugs."},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.286"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318248da90"},{"key":"e_1_3_2_3_8_1","unstructured":"Kemp AS SchollerNR KalaliAHet al.What is causing the reduced drug\u2013placebo difference in recent schizophrenia clinical trials and what can be done about it? Poster presented at: First Collaborative Session Between ISCTM and ISCDD. Brussels Belgium 18 September 2007."},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1470"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.03.013"},{"key":"e_1_3_2_3_11_1","first-page":"34","article-title":"Early phase drug development strategies to inform decision making and the viability of novel CNS compounds for schizophrenia.","volume":"5","author":"English BA","year":"2013","unstructured":"English BA , ThomasK, GertsikL, EreshefskyL.Early phase drug development strategies to inform decision making and the viability of novel CNS compounds for schizophrenia.J. Clin. Studies5 , 34\u201339 (2013).","journal-title":"J. Clin. Studies"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707658"},{"key":"e_1_3_2_3_13_1","first-page":"339","article-title":"Biomarkers for antipsychotic therapies.","author":"Pich EM","year":"2011","unstructured":"Pich EM , VargasG, DomeniciE.Biomarkers for antipsychotic therapies.Handb. Exp. Pharmacol.339\u2013360 (2011).","journal-title":"Handb. Exp. Pharmacol."},{"key":"e_1_3_2_3_14_1","first-page":"10","article-title":"Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients.","volume":"62","author":"Cutler NR","year":"2001","unstructured":"Cutler NR .Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients.J. Clin. Psychiatry62(Suppl. 5) , 10\u201313; discussion 23\u201324 (2001).","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_3_2_3_15_1","first-page":"811","article-title":"A bridging study of fananserin in schizophrenic patients.","volume":"34","author":"Sramek JJ","year":"1998","unstructured":"Sramek JJ , KirkesseliS, Paccaly-MoulinAet al. A bridging study of fananserin in schizophrenic patients. Psychopharmacol. Bull. 34 , 811\u2013818 (1998).","journal-title":"Psychopharmacol. Bull."},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/11634360-000000000-00000"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.12.020"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111414450"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2027"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.166"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.05.006"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.03.011"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr142"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.08.016"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110372547"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.12.001"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21436"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.194"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201665"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2013.08.017"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/65.1.169"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-1029-z"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.212"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3103-z"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0906-2"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2306-4"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1783-1"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.6.869"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.5.818"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.11.1525"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.7.921"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1981-9"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00199-8"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970410029903"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200501000-00003"},{"key":"e_1_3_2_3_46_1","first-page":"737","article-title":"Cerebellar and thalamic metabolic changes visualized by [18]-FDG-PET in olanzapine-induced acute akathisia.","volume":"27","author":"Landgrebe M","year":"2006","unstructured":"Landgrebe M , MarienhagenJ, LangguthB, SandP, EichhammerP, HajakG.Cerebellar and thalamic metabolic changes visualized by [18]-FDG-PET in olanzapine-induced acute akathisia.Neuro. Endocrinol. Lett.27 , 737\u2013739 (2006).","journal-title":"Neuro. Endocrinol. Lett."},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.0906e11"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm046"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.09.007"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.11.011"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.07.029"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.11.1229"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbq038"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr153"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbi020"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.04.011"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.01.027"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-009-0071-4"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318272d10c"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1191\/0269215506cr927oa"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2006.10.010"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr189"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.01.008"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301221"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.03.033"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1840-9"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0473-5"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06679.x"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050925"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00201.x"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2012.48.7.1832873"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs069"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2344-y"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.9.985"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.295"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107077733"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2011.08.004"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.009"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.3.270"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050503"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.06.045"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.03.012"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.02.017"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(01)02068-2"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.01.012"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/02643290701754158"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.10.1115"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.10.002"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.05.005"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm016"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-5597(93)90026-L"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(91)90034-O"},{"key":"e_1_3_2_3_93_1","first-page":"639","article-title":"Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.","volume":"17","author":"Adler LE","year":"1982","unstructured":"Adler LE , PachtmanE, FranksRD, PecevichM, WaldoMC, FreedmanR.Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.Biol. Psychiatry17 , 639\u2013654 (1982).","journal-title":"Biol. Psychiatry"},{"key":"e_1_3_2_3_94_1","first-page":"537","article-title":"Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.","volume":"18","author":"Freedman R","year":"1983","unstructured":"Freedman R , AdlerLE, WaldoMC, PachtmanE, FranksRD.Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.Biol. Psychiatry.18 , 537\u2013551 (1983).","journal-title":"Biol. Psychiatry."},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2007.2157"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.6.630"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90126-7"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.12.002"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.01.004"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/00034894021110S504"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.11.1001"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.11.021"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.06.003"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0388-x"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2005.07.007"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.02.009"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.537"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199223030-00003"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051003"},{"key":"e_1_3_2_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.04.006"},{"key":"e_1_3_2_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2010.10.004"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.10.002"},{"key":"e_1_3_2_3_113_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:BRAT.0000032866.20058.5c"},{"key":"e_1_3_2_3_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100861"},{"key":"e_1_3_2_3_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0737-8"},{"key":"e_1_3_2_3_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03902.x"},{"key":"e_1_3_2_3_117_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145708009814"},{"key":"e_1_3_2_3_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1982-8"},{"key":"e_1_3_2_3_119_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109106942"},{"key":"e_1_3_2_3_120_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122009836"},{"key":"e_1_3_2_3_121_1","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.09.021.2009"},{"key":"e_1_3_2_3_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282f39703"},{"key":"e_1_3_2_3_123_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004592"},{"key":"e_1_3_2_3_124_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152707779940835"},{"key":"e_1_3_2_3_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53702-7.00007-5"},{"key":"e_1_3_2_3_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-013-9301-9"},{"key":"e_1_3_2_3_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2427-9"},{"key":"e_1_3_2_3_128_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.09.39"},{"key":"e_1_3_2_3_129_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1443-y"},{"key":"e_1_3_2_3_130_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm901036q"},{"key":"e_1_3_2_3_131_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3647-11.2011"},{"key":"e_1_3_2_3_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820200009001"},{"key":"e_1_3_2_3_133_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318204d9e2"},{"key":"e_1_3_2_3_134_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.11.98"},{"key":"e_1_3_2_3_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(03)00101-8"},{"key":"e_1_3_2_3_136_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.637"},{"key":"e_1_3_2_3_137_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.5.624"},{"key":"e_1_3_2_3_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.08.021"},{"key":"e_1_3_2_3_139_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039480802571077"},{"key":"e_1_3_2_3_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-011-0280-9"},{"key":"e_1_3_2_3_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2575"},{"key":"e_1_3_2_3_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201200307"},{"key":"e_1_3_2_3_143_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900014048"},{"key":"e_1_3_2_3_144_1","first-page":"S16","article-title":"The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.","volume":"11","author":"Bodick NC","year":"1997","unstructured":"Bodick NC , OffenWW, ShannonHEet al. The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 11(Suppl. 4) , S16\u2013S22 (1997).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"e_1_3_2_3_145_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3930-09.2009"},{"key":"e_1_3_2_3_146_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200012)48:6<913::AID-ANA12>3.0.CO;2-S"},{"key":"e_1_3_2_3_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.08.056"},{"key":"e_1_3_2_3_148_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06937.x"},{"key":"e_1_3_2_3_149_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2678"},{"key":"e_1_3_2_3_150_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.093427"},{"key":"e_1_3_2_3_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12024"},{"key":"e_1_3_2_3_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.07.017"},{"key":"e_1_3_2_3_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.10.044"},{"key":"e_1_3_2_3_154_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.172957"},{"key":"e_1_3_2_3_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.04.035"},{"key":"e_1_3_2_3_156_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25758-2_12"},{"key":"e_1_3_2_3_157_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181f2288e"},{"key":"e_1_3_2_3_158_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb06860.x"},{"key":"e_1_3_2_3_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.12.001"},{"key":"e_1_3_2_3_160_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001556"},{"key":"e_1_3_2_3_161_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030327"},{"key":"e_1_3_2_3_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387718-5.00005-5"},{"key":"e_1_3_2_3_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318218d339"},{"key":"e_1_3_2_3_164_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05739yel"},{"issue":"4","key":"e_1_3_2_3_165_1","article-title":"Prolactin \u2013 a biomarker for antipsychotic treatment response?","volume":"13","author":"Agarwal SM","year":"2011","unstructured":"Agarwal SM , RaoNP, JhamnaniKet al. Prolactin \u2013 a biomarker for antipsychotic treatment response? Prim. Care Companion CNS Disord. 13(4) , pii: PCC.11l01155 (2011).","journal-title":"Prim. Care Companion CNS Disord."},{"key":"e_1_3_2_3_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2001.01308.x"},{"key":"e_1_3_2_3_167_1","doi-asserted-by":"publisher","DOI":"10.2190\/PM.44.1.b"},{"key":"e_1_3_2_3_168_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705005237"},{"key":"e_1_3_2_3_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.06.007"},{"key":"e_1_3_2_3_170_1","doi-asserted-by":"publisher","DOI":"10.1159\/000205518"},{"key":"e_1_3_2_3_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.03.010"},{"key":"e_1_3_2_3_172_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000277959.60604.d1"},{"key":"e_1_3_2_3_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30481"},{"key":"e_1_3_2_3_174_1","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2012.9.1.1"},{"key":"e_1_3_2_3_175_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2009.117"},{"key":"e_1_3_2_3_176_1","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.11.16"},{"key":"e_1_3_2_3_177_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09040598"},{"key":"e_1_3_2_3_178_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1819.2002.00935.x"},{"key":"e_1_3_2_3_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.07.001"},{"key":"e_1_3_2_3_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.08.012"},{"key":"e_1_3_2_3_181_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.7.822"},{"key":"e_1_3_2_3_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500477"},{"key":"e_1_3_2_3_183_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986707781368450"},{"key":"e_1_3_2_3_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2009.89"},{"key":"e_1_3_2_3_185_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1197"},{"key":"e_1_3_2_3_186_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.172"},{"key":"e_1_3_2_3_187_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63062259.x"},{"key":"e_1_3_2_3_188_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001237"},{"key":"e_1_3_2_3_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00088-4"},{"key":"e_1_3_2_3_190_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.06585.x"},{"key":"e_1_3_2_3_191_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1632587100"},{"key":"e_1_3_2_3_192_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.3"},{"key":"e_1_3_2_3_193_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095758"},{"key":"e_1_3_2_4_2_1","unstructured":"USFDA CDER. Clinical pharmacogenomics: premarket evaluation in early-phase clinical studies and recommendations for labeling (2013). www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM337169.pdf"}],"updated-by":[{"DOI":"10.2217\/bmm.13.56","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000}}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm.13.135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:59Z","timestamp":1719124739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm.13.135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,11]]},"references-count":194,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.2217\/bmm.13.135"],"URL":"https:\/\/doi.org\/10.2217\/bmm.13.135","relation":{"correction":[{"id-type":"doi","id":"10.2217\/bmm.13.56","asserted-by":"object"}]},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"value":"1752-0363","type":"print"},{"value":"1752-0371","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2013-12-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}